ASX News Health Care Neuren set for FDA talks on trial to treat developmental genetic disorders Neuren Pharmaceuticals is set to enter talks with the Us Food and Drug Administration about its… Caroline Smith2 mins07 February 2025 10:17 (AEDT)
ASX News Health Care Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%,… Caroline Smith1 min13 December 2024 14:58 (AEDT)
ASX News Health Care FDA awards Argenica two key designations for drug candidate targeting infant brain injury Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for… Caroline Smith2 mins30 October 2024 14:45 (AEDT)
ASX News Health Care Cashed up & ready to go: Mesoblast forges funding deal with top shareholder Mesoblast (ASX:MSB) is trading up more than 1.75% after striking a funding deal with its largest… Sonia Madigan1 min30 September 2024 11:20 (AEDT)
ASX News Health Care EBR reaches review milestone for wireless cardiac pacing device EBR Systems Inc has reached an important stage in its progress to commercialise its WiSE CRT… Caroline Smith1 min29 August 2024 13:09 (AEDT)
Contributors & Collaborations Dale Gillham’s weekly wrap: Will FDA tick give Mesoblast a boost? The sellers finally stepped in this week to push the All Ordinaries Index down more than… Dale Gillham4 mins26 July 2024 13:10 (AEDT)